Systemic chemotherapy for testicular cancer

Brian P. Mulherin, Noah M. Hahn, Lawrence Einhorn

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Testicular cancer is an uncommon malignancy, accounting for about 1% of all cancers in men. However, it represents the most common solid neoplasm in young adult males. Germ cell tumors are one of the most curable of all neoplasms, even in the metastatic setting. They are extremely sensitive to cisplatin-based combination chemotherapy, and surgical resection of residual disease has been shown to improve outcomes further. By combining chemotherapy, surgery, and sometimes radiotherapy, the vast majority of patients can now be cured. Testicular cancer has become a model for a curable neoplasm.

Original languageEnglish
Title of host publicationEssentials and Updates in Urologic Oncology (2 Volume Set)
PublisherNova Science Publishers, Inc.
Pages607-630
Number of pages24
ISBN (Print)9781620816493
StatePublished - 2012

Fingerprint

Chemotherapy
Testicular Neoplasms
Drug Therapy
Radiotherapy
Surgery
Cisplatin
Tumors
Neoplasms
Cells
Germ Cell and Embryonal Neoplasms
Combination Drug Therapy
Young Adult

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Mulherin, B. P., Hahn, N. M., & Einhorn, L. (2012). Systemic chemotherapy for testicular cancer. In Essentials and Updates in Urologic Oncology (2 Volume Set) (pp. 607-630). Nova Science Publishers, Inc..

Systemic chemotherapy for testicular cancer. / Mulherin, Brian P.; Hahn, Noah M.; Einhorn, Lawrence.

Essentials and Updates in Urologic Oncology (2 Volume Set). Nova Science Publishers, Inc., 2012. p. 607-630.

Research output: Chapter in Book/Report/Conference proceedingChapter

Mulherin, BP, Hahn, NM & Einhorn, L 2012, Systemic chemotherapy for testicular cancer. in Essentials and Updates in Urologic Oncology (2 Volume Set). Nova Science Publishers, Inc., pp. 607-630.
Mulherin BP, Hahn NM, Einhorn L. Systemic chemotherapy for testicular cancer. In Essentials and Updates in Urologic Oncology (2 Volume Set). Nova Science Publishers, Inc. 2012. p. 607-630
Mulherin, Brian P. ; Hahn, Noah M. ; Einhorn, Lawrence. / Systemic chemotherapy for testicular cancer. Essentials and Updates in Urologic Oncology (2 Volume Set). Nova Science Publishers, Inc., 2012. pp. 607-630
@inbook{a5e76395b0324519802982f8b7e0f473,
title = "Systemic chemotherapy for testicular cancer",
abstract = "Testicular cancer is an uncommon malignancy, accounting for about 1{\%} of all cancers in men. However, it represents the most common solid neoplasm in young adult males. Germ cell tumors are one of the most curable of all neoplasms, even in the metastatic setting. They are extremely sensitive to cisplatin-based combination chemotherapy, and surgical resection of residual disease has been shown to improve outcomes further. By combining chemotherapy, surgery, and sometimes radiotherapy, the vast majority of patients can now be cured. Testicular cancer has become a model for a curable neoplasm.",
author = "Mulherin, {Brian P.} and Hahn, {Noah M.} and Lawrence Einhorn",
year = "2012",
language = "English",
isbn = "9781620816493",
pages = "607--630",
booktitle = "Essentials and Updates in Urologic Oncology (2 Volume Set)",
publisher = "Nova Science Publishers, Inc.",

}

TY - CHAP

T1 - Systemic chemotherapy for testicular cancer

AU - Mulherin, Brian P.

AU - Hahn, Noah M.

AU - Einhorn, Lawrence

PY - 2012

Y1 - 2012

N2 - Testicular cancer is an uncommon malignancy, accounting for about 1% of all cancers in men. However, it represents the most common solid neoplasm in young adult males. Germ cell tumors are one of the most curable of all neoplasms, even in the metastatic setting. They are extremely sensitive to cisplatin-based combination chemotherapy, and surgical resection of residual disease has been shown to improve outcomes further. By combining chemotherapy, surgery, and sometimes radiotherapy, the vast majority of patients can now be cured. Testicular cancer has become a model for a curable neoplasm.

AB - Testicular cancer is an uncommon malignancy, accounting for about 1% of all cancers in men. However, it represents the most common solid neoplasm in young adult males. Germ cell tumors are one of the most curable of all neoplasms, even in the metastatic setting. They are extremely sensitive to cisplatin-based combination chemotherapy, and surgical resection of residual disease has been shown to improve outcomes further. By combining chemotherapy, surgery, and sometimes radiotherapy, the vast majority of patients can now be cured. Testicular cancer has become a model for a curable neoplasm.

UR - http://www.scopus.com/inward/record.url?scp=84895323395&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84895323395&partnerID=8YFLogxK

M3 - Chapter

AN - SCOPUS:84895323395

SN - 9781620816493

SP - 607

EP - 630

BT - Essentials and Updates in Urologic Oncology (2 Volume Set)

PB - Nova Science Publishers, Inc.

ER -